The patient needed analgesia. He had a below-the-knee amputation on his left leg,
cervical degeneration, and neuropathic pain. But when his pharmacist tried to figure
out the source of hallucinations during methadone therapy, it was pharmacogenetics
that proved the missing link.
To read this article in full you will need to make a payment
APhA Member Login
APhA Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
Already an online subscriber? Sign in
© 2013 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.